mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.4 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |